INTRODUCTION
Macrophages (Ma) are of central importance in the imtiation and regulation of non-specific and specific immune responses. They take part as active phagocytic cells. serve as antigen presenting cells (APC) for Tlymphocytes and are a major source of a wide range of inflammatory products including eicosanoids and qtokines in different types of immune responses (e.g. host defence against microorganism, antitumor and chronic inflammation).
When monocytes or tissue Me are stimulated. both develop into active MO. Profound changes then occur in morphology and function. Major changes are: increase in size, more complex and numerous surface folds and an increase in the numbers of vacuoles, lysosomes. phagosomes and endoplasmatic reticular elements. The adhesiveness and expression of Ia antigens increases. The M@ become more sensitive for agents which trigger oxygen radicals and +y__s_ecrete a large range of products including enzymes. coagulation factors, proteins of complement system. factors regulating cell activities and proliferation, bioactive lipids. nucleotide metabolites and reactive oxygen metabolites (1.2).
In vivo M@ activation appears to be mediated and/or modulated by microbial pathogens and their products, lipid mediators and cytokines (3. 4) . In vitro activation can be initiated by a variety of agents. including calcium ionophore A23 I X7 (A23 I X7) (5 ), lipopolysaccharide (LPS) (6, 7) or cytokines (8. 9) . The cytokines interleukin-I (IL-1 ) ( IO). interleukin-6 (IL-6) ( I I ) and tumor necrosis factor (TNF-a~ ( 12) are important Mti cytokine products when stimulated with LPS (7). which is one of the most potent stimuli of MC? ( 13).
Arachidonic acid can be metabolized to biologically active eicosanoids. The cyclooxygenase pathway generates the prostanoids and the 5-lipoxygenase pathway produces leukotriene B, (LTB,) and 5-hydroxyeicosatetraenoic acid (5-HETE) (14, 15) . Eicosanoids exhibit distinct biological effects (1619) .
Like the cytokines they have an important function in controlling the immune reaction. A23 187 is one of the most potent stimuli of eicosanoid production (5, 20, 21) .
The respiratory burst is a characteristic feature of phagocytes. The production and release of radical oxygen intermediates (ROI) by Mo plays a major role in several of the effector functions of these cells. Oxygen radicals are of critical importance for antibacterial defence. They are also involved in tumoricidal activities, in suppression of lymphocyte proliferation (22, 23) and have been implicated as important mediators of tissue damage in inflammation (24, 25) . Oxygen radicals may be involved in a positive feedback mechanism of inflammation; superoxide anion (0;) can induce IL-I production in monocytes and polymorphonuclear leucocytes (PMNs) (26).
We have previously isolated human peritoneal Mo (hp-Mo) from ascitic fluid, obtained from patients with liver cirrhosis to investigate various aspects of their metabolism and the role of Mo in inflammation (27, 28) . The aim of this study is to analyze the profile of eicosanoid production, the levels of cytokine production and the respiratory burst activity in this type of hp-Mo, regarding the potential influence of liver disease on these parameters, in comparison with other types of
MB.

MATERIALS AND METHODS
Subjects
The hp-Mo were obtained from ascitic fluid of 12 patients with liver cirrhosis. 2 patients with congestive heart failure, 1 patient with primary slcerosing cholangitis, 1 patient with malignant mesothelioma and 1 patient with the Budd-Chiari syndrome (Table 1) . None of the patients were on drugs which have been reported to influence the lipoxygenase and cyclooxygenase enzymes.
Cell isolation
The hp-cells were isolated by centrifugation of the ascitic fluid at 400xg (4°C) and washed with phosphate buffered saline (PBS, pH 7.4, 4°C Oxoid, UK). The concentrated hp-cell suspension was separated on Percoll (d = 1.064 g/ml, Kabi-Pharmacia, Sweden). A small sample of cells was stained by Hemacolor (Merck, Germany) and the different cell types were counted under a microscope (Zeiss, standard 25, Germany). The viability of the cells was tested by trypan blue exclusion. 
Cytokine production
For the measurement of the cytokine production one million leucocytes per ml RPM1 (RPMI-1640 + HEPES (GIBCO, UK) + penicillin/streptomycin (5 x lo4 p/l / 50 mg/l, Flow Lab, UK) + foetal calf serum (FCS) (10% FCS, GIBCO, UK) + L-glutamine (600 mg/l Flow Lab, UK)) were plated on plastic culture dishes (Costar, UK). The cells were stimulated with the addition of increasing concentrations of lipopolysaccharide (O-10 pg/ml, 36 h, LPS from E. coli 011 l:B4 in PBS, Sigma, USA) or incubated in the absence or presence of LPS (10 pg/mll for an increasing time period (O-36 h, 37"C, 7.5% CO?). As blanc PBS was added. The net cytokine production is the production with LPS minus blanc of cells incubated for the same period of time. At the end of the incubation the supernatant was filtered (0.22 pm, Millipore, France) and kept at -70°C till analyzing. IL-lb and IL-6 production in the supematant of the samples were measured by ELISA (IL-lfi: Medgenix, Belgium, IL-6: Hycult, Holland). Tumour necrosis factor-a (TNF-a) production of the samples was determined with a bioassay and partly by ELISA (Cistron, USA). For this bioassay the TNF-a sensitive cell line WEHIwas used. The WEHI-164 cells were plated out in 96-wells plates (2 x IO4 cells/50 pi/well, Costar, UK) and the samples (50 pl/ well) or the human recombinant TNF-a (hr-TNF-a) standards (0.1-1000 p/ml hr-TNF-a, 50 @/well) were added. After 24 h of incubation (37°C 7.5% CO?), MTT (Tetrazolium salt, Sigma, USA) was added (0.125 mg/ well) and after an incubation of 3 h the cells were lysed with buffer (20% sodium dodecyl sulphate (SDS) in 50% N,N-dimethylformamide (DMF), pH 4.7, 100 pl/ well) during 18 h. The absorbance was measured at 595 nm with an ELISA-reader (BIO RAD, model 3550, UK). The TNF-cr production by hp-Mo is expressed as the cytotoxicity against WEHIcells compared to blanc (RPM1 complete) (29) .
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Eicosanoid production
For the measurement of eicosanoid production from exogenous arachidonate, I x lo6 leucocytes per ml PBS (+ Ca'+. pH 7.4, Oxoid, UK) in polypropylene tubes (Greiner, The Netherlands)
were labelled with 14C-arachidonic acid t "'C-AA) (0.125 pCi, 55.7 MCilmmol, Amersham, UK) for 2 min and triggered by A23 187 (O-5 pM final concentration in dimethylsulfoxide (DMSO, Sigma, USA) for 13 min at 37°C. Controls were incubated with DMSO. "H-labelled standards consisting of 6kPGF,,, prostaglandin EZ (PGE,), leukotriene B1 (LTB,). 12-HETE and 15-HETE (approximately 0.01 pCi of each eicosanoid, Amersham, UK) were added for recovery calculations and as retention time markers. The supernatants were then passed through Sep Pak C,, cartridges (Waters Ass., USA) and eluted with methanol.
dried and dissolved in 200 1.11 methanol. Eicosanoid formation was measured on RP-HPLC using a Nucleosil 5C,% column (3 x 200 mm), Chrompak, The Netherlands).
100 pl sample was injected onto the coiumn. As eluens a gradient of acetonitrile and 0.2% triethylamine/O. 132% trifluoracetic acid/water (pH > > 3) was used. The eicosanoid formation is expressed as the mean % of total formation of the most common metabolites per patient. In these samples. both A23187 stimulated and non-stimulated, eicosanoid production horn endogenous arachidonate was measured (LTB4, PGE,, thromboxane BZ (TXB?) and 6kPGF,,). In the cytokine samples (24 h, 10 pg/ml LPS In RPMI) also the eicosanoid production from endogenous arachidonate was measured by radio immuno assays (antibodies were obtained from Advanced Magnetics, USA and standards from Sigma, USA). The exogenous eicosanoid production is given as net production. This is the production of the cells with A23 187 minus control values.
Respiratory burst activity
ROI production was measured with dihydrorhodamine 123 (DHR 123. Molecular probes, USA). The stock solurion was 1 mg/ml in N,N-dimethylformamide (Sigma, USA); further dilution was performed with PBS. DHR 123 is oxidized intracellularly to fluorescent rhodamine 123 (R123) by hydrogen peroxide.
Leucocytes (0.25 x 106/ml) were incubated in RPM1 in polypropylene tubes with increasing concentrations of phorbol 12-myristate 13-acetate (0 -1000 @ml, TPA diluted in DMSO: PBS = l:lO, Sigma, USA, l(, min, 37°C blanc is 10% DMSO) directly followed by incubations with increasing concentrations of DHR 123 (0_100ng/ml, 15 min, 37°C). In the time experiments TPA and DHR 123 were added to the cells at the same time and incubated for an increasing time period (O-l h, 100 ng/ml TPA, 333 ng/ml DHR 123, 37°C). Samples were put on ice straight after the incubations. The fluorescence intensity (mean channel number (MCN) was measured with a fluorescence activating cell scanner (FACS, Becton Dickinson Immunocytometry Systems, USA). R 123 is detected as Fluorescence 1 (green; 500-530 nm) (30, 3 1) . 5000 cells per sample were measured. The data were evaluated with the FACS SCAN program system (Becton Dickinson Immunocytometry Systems, USA). The net ROI production is the fluorescence intensity (in MCN) of the TPA stimulated and DHR 123 loaded cells, minus the fluorescence intensity (in MCN) of the non-stimulated cells which were also loaded with DHR 123 and incubated for the same period of time.
Statistical analysis
The data are expressed as the mean + SEM. Data were statistically analyzed with Anova followed by the Student's t-test or the Student's t-test only; data were considered significant when p < 0.05.
RESULTS
Cell differentiation
The Percoll separated cell suspension was microscopically examined and the following composition of cells was found: 94.6 + 1.2% Mo, 4.0 + 1.1% lymphocytes and 1.2 f 0.4% granulocytes (n = 17 ). The viability of the cells was 86 + 1.3% (range: 94.2-75.8).
Cytokine production
To determine LPS concentration for optimal IL-1 p, IL-6 and TNF-a production, hp-Mo were stimulated with increasing concentrations of LPS (O-10 yg/ml) for 36 h as shown in Figure 1 . The highest production was with the highest LPS concentration used. All subsequent experiments were performed with 10 pg/ml LPS.
The time dependent net IL-lb, IL-6 and TNF-a production from O-36 h with LPS is shown in Figure 2 . The maximal net cytokine production for all three cytokines was reached at 24 h.
The IL-lp (n = 16) IL-6 (n = 10) and TNF-cr (n = lO/ 17) production without or after stimulation with 10 pg/ ml LPS for 24 h is shown in Table 2 . LPS stimulation resulted in a significant increase in the production of each cytokine. Mel from 6 out of 16 patients had no IL-10 production without LPS, all patients had IL-6 production without LPS stimulation and 6 out of IO patients had no TNF-a production without LPS.
Eicosanoid production
First the A23187 concentration was determined (O-5 PM) which yielded the most eicosanoid production. Figure 3 (top and middle) shows the LTB, and 5-HETE production from added 14C-AA (exogenous production) and The main net eicosanoids were the 5-lipoxygenase as measured by radioimmunoassay (RIA) of 3 patients. products LTB, and SHETE, the minor net eicosanoids The optimal concentration is l-2 FM. Consequently were the cyclooxygenase products HHT and TXB,. all following experiments were performed with 1 PM Other eicosanoids were less then 1.5% of 14C-AA which A23187.
was converted per product. All eicosanoids formed from exogenous arachidonate To investigate if eicosanoid production from exoby hp-Mo after A23187 stimulation are listed in other, four eicosanoids were measured in the same samples by RIA, as in which "C-AA conversion was determined by HPLC (Table 3b ). The main eicosanoid was also a S-lipoxygenase product (LTB,). Cyclooxgenase production did not increase significantly with A23187.
Furthermore eicosanoid production from endogenous arachidonate was measured in the same samples as in which the cytokine production was measured (24 h LPS). LPS did not significantly influence eicosanoid production from endogenous arachidonate over 24 h as measured by RIA (Table 4) .
Respiratory burst
To measure the respiratory burst activity of the hp-Mo, the method published by Emmendorffer et al using di hydrorhodamine DHR 123 for human neutrophils (3 1) was modified for peritoneal Mo. The optima1 net for- mation of ROI loaded with (DHR 123) ((~1000 ng/ml, 10 min) and stimulated with phorbol 12-myristate 13-acetate (TPA) (G-1000 ng/ml, 1.5 min) is given in Figure 4 (top left and top right). All subsequent experiments were performed with 100 ng/ml TPA and 333 ng/ml DHR 123. To check whether this method depended on the cell activity, the ROI production was also measured in cells (n = 4) which were kept on ice during the stimulation and loading (10 + 15 mins.). In Figure 4 (left bottom) the temperature dependency for the ROI production at 4°C (n = 4) and 37°C (n = 10) is shown. There was no significant ROI production increase at 4°C but TPA increased the net ROI production significantly at 37°C. The respiratory burst activity dependence on the time of stimulus is shown in Figure 4 (bottom right). The ROI production was significantly different after 15 min of stimulation. DHR 123 and TPA were given at the same time now. In previous experiments we have shown that ascites is a good source of hp-Mo which can be used to study eicosanoid production by human Mo (27, 28, 32) . These Me, can be used as a model for testing the effects of anti-inflammatory drugs on the eicosanoid production in vitro, as we have shown previously with drugs such as malotilate (33) and E6080 (34) . By gaining more information on the inter-relationships between the inflammatory mediators, such as eicosanoids, cytokines and oxygen radicals of the hp-Me, we expect to expand our ex vivo anti-inflammatory drug testing model with human inflammatory cells. The aim of this study was to characterize in addition to the eicosanoid production other cell functions of hp-Mo including cytokine production and respiratory burst activity.
Results
We investigated the cytokine production of hp-Mo (0) and DHR 123 were given at the same time (t =0-I h, 100 ng/ml TPA, 333 ng/ml DHR 123.37"C. n = 3). The ROI production is expressed as % increase of maximal increase (=lOO%) per patient with TPA. Data are expressed as mean + SEM and statistically significant (*) when p < 0.05 vs controls (t = Oh).
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stimulated with LPS as this is an important stimulus for Mo in vivo (7, 13). The eicosanoid production was determined both with LPS and A23 187 as this stimulus is known to be a potent trigger for lipoxygenase products derived from Mo (20, 21. 5) .
The experiments showed that the production of the cytokines IL-lb. IL-6 and TNF-a was LPS concentration dependent and also dependent on the time of expo\ure to the stimulus. LPS stimulation influenced the net IL-1 p, IL-6 and TNF-a production significantly, but did not have an appreciable effect on the eicosanoid production from endogenous arachidonate. A short stimulation with A23 187 gave a significant increase in lipoxygenase products from exogenous and endogenous arachidonate.
The eicosanoid production from exogenous and endogenous amchidonate depended on the .X3 187 concentration.
Production of measurable amounts of ROI in vitro of the hp-Mo can be triggered by TPA. With the lowest concentration of the stimulating agent the ROI production was maximal. higher concentrations of TPA did not change the level of production. The measurement of ROI production was DHR 123 concentration dependent. Beyond 333 ng/ml the ROI production slightly decreased. the DHR 123 concentration was no longer a limiting factor. With optimal concentrations of TPA and DHR 123 the net respiratory burst activity increased significantly. When stimulus and DHR 123 were given at the same time. the increase was significant after 15 min.
Comparison of cytokine and eicosanoid production in MB from different species and/or origin Similar kinetics as we had found for LPS induced cytokine production have been previously reported for human alveolar Mo (35) (36) (37) hp-Mo obtained from continuous ambulatory peritoneal dialysis (CAPD) patients I 3X, 39) . a murine macrophage cell line (40) and murine peritoneal Mo (41, 43) . In all these observations the ;ytokine production increased with increasing LPS conLentration with a maximun in the range l-10 ug/ml LPS. Human alveolar Mo had with LPS a maximal IL-lb I O-43 h and IL-6 (O-72 h) production by 24 h (a slight increase at 72 h for IL-6) (35, 36) .
The IL-I production of the murine macrophage cell linz P388D 1 (e-1 8 h) and murine peritoneal Mo (Alderey Park, O-23 h) increased in time with LPS (40, 42) . Peritoneal Mo from C3H/HEN and C3H/HEJ mice had lvith LPS (O-72 h) a maximal IL-I production at 24 h !-I ). The IL-6 production was maximal between 8-12 h tb~ the murine macrophage cell line (40) .
TNF-a production of Me, of other origin or species usually reached a maximal level at an earlier time than our hp-Mo. TNF-cx (W2 h) production of human alvec)lar Mo peaked between 4-8 h (35) . The murine macrophage cell line stimulated with LPS reached a plateau at 2 h (40) . Rat peritoneal Mo reached a maximum at 6 h (44) and guinea pig peritoneal Mo around 8 h (45).
In our experiments LTB4 and 5-HETE were the main eicosanoids formed (89%). when the Mo were stimulated with A23 187. In normal bovine alveolar Mo A23 187 stimulated the release of both the cyclooxygenase and lipoxygenase products (21), also in resident mouse peritoneal Mo (46, 47) . Rat peritoneal Mo and rat Kupffer cells mainly synthesized cyclooxygenase products after A23 187 stimulation (32) .
In alveolar Me, from healthy volunteers. exogenous AA was predominantly metabolized via the S-lipoxygenase pathway (20, 48, 49) . but also cyclooxygenase products were formed. when stimulated with A23 187 (20, 49) .
Leukotrienes are known to mediate inflammatory reactions. LTBl is an important chemotactic agent for leucocytes c 16), generates superoxide anion in neutrophils ( 17). whereas the sulfidopeptide LTs (LTC,, LTDJ and LTE,) primarily affect smooth muscle contraction. increase vascular permeability ( 18 1 and promotes lysosomal enzymes (19). Specific inhibition of the enzyme S-lipoxygenase has therapeutical potential in a variety of inf-lammatory conditions shown by different animal models and clinical trials (50-52) and as mentioned before we have tested the drugs malotilate (33) and E6080 (34) on the eicosanoid production in our in vitro model.
The pattern of eicosanoid metabolism depends on the stimulus applied (30, 21, 48) . as well as the maturity of the cell (49), site of origin of macrophage and the species (32) . In relation to this, in vivo priming might be another important point for influencing the eicosanoid and cytokine profile when the cells are stimulated in vitro. Cytokines and eicosanoids also regulate their own and each other's release in vivo and in vitro (53-55). The exact interaction of these mediators involved in human macrophage inflammation still has to be investigated.
Comparison of cytokine and eicosanoid production in hp-M@ from liver cirrhosis and CAPD patients
The high cytokine production of our hp-Mo with LPS was probably due to priming of the cells in vivo. The patients, where the cells were isolated from. have a chronic inflammation. Peritoneal Mo obtained from CAPD patients during peritonitis and compared to Mo obtained from the same type of patients during an infection free period, stimulated with LPS in vitro, released significantly more IL-I p and TNF-a (39. 56) whereas their prostacyclin release (measured as 6kPGF,,,. without and with LPS) had declined sharply (38 j.
The TNF-cx bioactivity of the liver cirrhosis Mo seems lower then Ms of CAPD patients with peritonitis. however TNF-a was measured by different bioassay\. Although the methods are comparable the % killing is higher with the 'H-thymidine incorporation cytostatic assay compared to the MTT tetrazolium cytotoxic assay (29) . Therefore the TNF-cx bioactivity of hp-Mo, from liver cirrhosis patients compared to Mo from CAPD patients with peritonitis could be in the same range. The concentrations of TNF-a measured by ELISA in supematants of liver cirrhosis patients however showed a TNF-a production comparable to M@s from CAPD patients without peritonitis.
A pronounced difference between the MO from liver cirrhosis and the Ma of CAPD patients with peritonitis was observed in the PGE? production. The PGE? release of human peritonitis MO without LPS was initially much higher than the hp-Mp, in our observations. Furthermore a significant increase in PGEz production in response to LPS was seen (no difference compared to infection-free MO of CAPD patients). In conclusion the M@s of liver cirrhosis patients have striking features with M@s from CAPD patients with peritonitis (Table 5) .
Oxygen radical production
In response to TPA the ability to generate oxygen radicals was enhanced. TPA stimulates the intracellularly and extracellularly respiratory burst of phagocytes (57, 58). The flow cytometric method we have used here reflects the total production of H202 inside single, stimulated, cells. DHR 123 is oxidized by a hydrogen peroxide and peroxidase dependent system. This method with DHR 123 seemed to be a highly sensitive indicator for the respiratory burst (59-61). In comparison with human monocytes and neutrophils the respiratory burst of monocyte-derived MO was very low when measured with the luminol-amplified chemiluminescence assay (61). which measures intra-and extracellular H201 and O'-(58). We were able to measure with DHR 123 a clear increase in the respiratory burst activity, when the MO were stimulated with TPA. Our results were similar to Banati (30) whom measured the respiratory burst of rat peritoneal MO with DHR 123. The MO exhibit spontaneous respiratory burst activity before stimulation and after stimulation the fluorescence intensity had increased about a factor 3. our ROI production (in MCN) increased a factor 2.4. Table 5 Comparison of cytokine and PC synthesis by human peritoneal macrophages from liver cirrhosis and CAPD patients without and with peritonitis. Compared are the eicosanoid and cytokine synthesis without stimulus (24 h PBS = blancs) and with stimulus (24 h LPS = LPS). LPS = 5 pg/ml CAPD hp-Md (IOh cells/ ml) and 1 Opg/ml with liver cirrhosis hp.M@ (I 0" cells/ml) . n = number of patients Liver cirrhosis (this study) n CAPD (38, 39, 56) 
Conclusion
Ascitic fluid is an easily available source of large quantities of hp-MO. In this study we have characterized the eicosanoid and cytokine production and respiratory burst activity of human MO isolated from peritoneal ascitic fluid. The IL-lb, IL-6 and TNF-or kinetics of hp-MO stimulated with LPS is similar to that of human lung MO, peritoneal Me of CAPD patients and peritoneal Mp, of other species. The cytokine production is LPS concentration dependent and dependent on the time of exposure to LPS. The profile of eicosanoid production depends on both the species origin, location and the stimulus applied. LPS did not effect the eicosanoid production from endogenous arachidonate of the hp-MB, while a stimulation with A23187 both increased the lipoxygenase production from exogenous and endogenous arachidonate. The MO of liver cirrhosis patients have striking features with Me from CAPD patients with peritonitis, probably due to priming of the Me, in vivo.
With optimal concentrations of TPA and DHR 123 the net respiratory burst activity in the hp-M# increased significantly. Whether a relation exists between formation of cytokines and eicosanoids and the respiratory burst activity of the hp-M@ still has to be examined. Characterization of hp-M@ function show that ascites may be a promising source of MO to set up a model for testing the effects of anti-inflammatory drugs in vitro on different types of inflammatory mediators produced by human Mei.
